IT: L’industria della bellezza si sta spostando dalla correzione dei danni visibili all’individuazione precoce di cambiamenti molecolari, che favoriscono la resilienza a lungo termine. Questo intervento introduce modelli trascrittomici avanzati in vitro e in vivo, progettati per proteggere la pelle nel tempo attraverso metodologie innovative come la mappatura delle risposte di espressione genica fino al sequenziamento dell’RNA. Come trasformare la classica promessa di prevenzione in solidi Claim di “longevità” basati su biomarcatori e supportati da evidenze genetiche non invasive e all’avanguardia? Scopriamolo insieme.

ENG: The beauty industry is shifting from correcting visible damage to detecting early molecular changes that support long-term resilience. This session introduces advanced in vitro and in vivo transcriptomic models, designed to protect skin over time through innovative methodologies ranging from gene expression response mapping to RNA sequencing. How can we turn the classic promise of prevention into solid “longevity” claims — backed by biomarkers and supported by cutting-edge, non-invasive genetic evidence? Let’s find out together.

The beauty industry is shifting from correcting visible damage to detecting early molecular changes that support long-term resilience. This session introduces advanced in vitro and in vivo transcriptomic models, designed to protect skin over time through innovative methodologies ranging from gene expression response mapping to RNA sequencing.

How can we turn the classic promise of prevention into solid "longevity" claims — backed by biomarkers and supported by cutting-edge, non-invasive genetic evidence? Let's find out together.